← Leaderboards
Wendy Ann Goodman
Case Western Reserve University
$3,094,508
Attributed
$3,094,508
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $540.5K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,094,508 · 4
By mechanism
R01$2,237,890 · 1
K01$566,720 · 1
R03$241,500 · 1
F32$48,398 · 1
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Maneesh Dave$1,684,839
- Fabio Cominelli$30,550,057
- Theresa Torres Pizarro$21,932,219
- Abigail Raffner$674,035
- Claudio Fiocchi$14,319,606
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsSignal TransductionIn VivoPhenotypeMediatingChronicEnvironmentTranscriptome SequencingIntestinesCrohn&AposIleitisFemaleCell PhysiologyS DiseaseEstrogensRegulatory T-LymphocyteEstradiolInflammatory Bowel DiseasesExhibitsResistanceT-LymphocytePathogenesisInflammationMolecular
Grant awards (15)
Estrogen-mediated immune regulation in human and experimental inflammatory bowel disease$394,551
R01 · FY2025 · DK · contact PI
Estrogen-mediated immune regulation in human and experimental inflammatory bowel disease$413,657
R01 · FY2024 · DK · contact PI
Estrogen-mediated immune regulation in human and experimental inflammatory bowel disease$62,790
R01 · FY2024 · DK · contact PI
Estrogen-mediated immune regulation in human and experimental inflammatory bowel disease$458,148
R01 · FY2023 · DK · contact PI
Estrogen-mediated immune regulation in human and experimental inflammatory bowel disease$31,395
R01 · FY2023 · DK · contact PI
Estrogen-mediated immune regulation in human and experimental inflammatory bowel disease$457,578
R01 · FY2022 · DK · contact PI
Estrogen-mediated immune regulation in human and experimental inflammatory bowel disease$419,771
R01 · FY2021 · DK · contact PI
Role of regulatory T cell glucocorticoid-induced leucine zipper (GILZ) in the chronically inflamed intestine$120,750
R03 · FY2021 · DK · contact PI
Role of regulatory T cell glucocorticoid-induced leucine zipper (GILZ) in the chronically inflamed intestine$120,750
R03 · FY2020 · DK · contact PI
Molecular mechanisms contributing to gender differences in regulatory T cell function in Crohn's disease and experimental IBD$113,044
K01 · FY2019 · DK · contact PI
Molecular mechanisms contributing to gender differences in regulatory T cell function in Crohn's disease and experimental IBD$113,044
K01 · FY2018 · DK · contact PI
Molecular mechanisms contributing to gender differences in regulatory T cell function in Crohn's disease and experimental IBD$113,044
K01 · FY2017 · DK · contact PI
Molecular mechanisms contributing to gender differences in regulatory T cell function in Crohn's disease and experimental IBD$113,044
K01 · FY2016 · DK · contact PI
Molecular mechanisms contributing to gender differences in regulatory T cell function in Crohn's disease and experimental IBD$114,544
K01 · FY2015 · DK · contact PI
KLF2 as a Regulator of Metabolic Inflammation$48,398
F32 · FY2012 · HL · contact PI